drugset / Trial / NCT03633344

Efficacy of the Administration of Colloidal Silicon Dioxide in Tablet Dosage Form in Patients With Acute Diarrhea

NCT03633344 ↗

Phase 2 Completed 145 enrolled Omnifarma Kiev LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to demonstrate the antidiarrheal efficacy of colloidal silicon dioxide in tablet dosage form (Carbowhite) in patients with acute diarrhea.

Timeline

Start
2016-03-29
Primary completion
2016-10-07
Completion
2016-10-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbowhite Unknown 630 mg —

Indications